FY2025 · ended Dec 31, 2025 · Revenue $319.02M, -37.5% YoY · Filed Mar 2, 2026
Core Scientific, Inc./tx (CORZ) files with the SEC under industry code 6199, Finance Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $319.0 million and a net loss of $288.6 million. Free cash flow was -$450.8 million. As of Jun 30, 2026 it held $1.8 billion in cash and investments and $4.4 billion in total debt.
Revenue (TTM)
$440.31M
+26.4% vs year-ago TTM
Net income (TTM)
$-1.43B
-29.2% vs year-ago TTM
Operating cash flow (TTM)
$520.24M
+6037.1% vs year-ago TTM
Free cash flow (TTM)
$-957.75M
-273.1% vs year-ago TTM
EPS (TTM)
$-5.07
-42.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
315.33M
+7.2% vs prior year
Net cash
$-2.64B
as of Jun 30, 2026
Operating margin
-127.4%
FY 2026
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- CORZ (Nasdaq), CORZR (OTC), CORZW (Nasdaq), CORZZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dover, DE
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1839341
- Former names
- Power & Digital Infrastructure Acquisition Corp. (until Jan 19, 2022)
Other Finance Services companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $319.0M | $510.7M | $502.4M | $640.3M | — |
| Operating income | -$245.6M | -$142.1M | $9.0M | -$2.1B | $131.5M |
| Net income | -$288.6M | -$1.4B | -$246.5M | -$2.1B | $47.3M |
| Diluted EPS | -$0.88 | -$4.87 | -$0.65 | -$6.30 | — |
| Operating cash flow | $278.2M | $42.9M | $65.1M | $205.2M | -$56.7M |
| Free cash flow | -$450.8M | -$52.1M | $49.0M | -$178.8M | — |
| Total assets | $2.3B | $1.5B | $712.2M | $807.7M | $2.4B |
| Total liabilities | $3.3B | $2.4B | $1.3B | $1.2B | $1.1B |
| Stockholders' equity | -$962.7M | -$943.0M | -$596.9M | -$409.3M | $1.3B |
| Cash and investments | $311.4M | $836.2M | $50.4M | $15.9M | $117.9M |
| Total debt | $102.2M | $109.5M | $57.1M | $1.5M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Aug 27, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
All 681 Core Scientific, Inc./tx SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.